BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/12/2021 11:22:24 AM | Browse: 512 | Download: 904
 |
Received |
|
2021-02-23 20:50 |
|
Peer-Review Started |
|
2021-02-23 20:55 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-19 04:58 |
|
Revised |
|
2021-04-25 19:10 |
|
Second Decision |
|
2021-09-02 02:54 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-09-02 06:19 |
|
Articles in Press |
|
2021-09-02 06:19 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-09-09 00:25 |
|
Typeset the Manuscript |
|
2021-11-04 10:19 |
|
Publish the Manuscript Online |
|
2021-11-12 11:22 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Gut microbiota and immune system in liver cancer: Promising therapeutic implication from development to treatment
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ilenia Bartolini, Matteo Risaliti, Rosaria Tucci, Paolo Muiesan, Maria Novella Ringressi, Antonio Taddei and Amedeo Amedei |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Amedeo Amedei, PhD, Professor, Department of Experimental and Clinical Medicine, SOD of Interdisciplinary Internal Medicine, Azienda Ospedaliero Universitaria Careggi (AOUC), Largo Brambilla 3, Florence 50134, Italy. amedeo.amedei@unifi.it |
| Key Words |
Gut microbiota; Immune system; Liver cancer; Primary liver cancer; Colorectal liver metastasis; Liver cancer treatment |
| Core Tip |
Liver cancer is a worldwide leading cause of death. Growing evidence suggested a pathogenetic role of the gut microbiota and immune system in liver cancer development. Although rapid developments in metagenomic science, definitive and complete knowledge of these processes is still far from being acquired. However, targeting both microbiota and the immune system could represent an appealing therapeutic option alone or as a boost of conventional treatments. Finally, the microbiota signature evaluation could represent a potential novel, non-invasive biomarker for early diagnosis. |
| Publish Date |
2021-11-12 11:22 |
| Citation |
Bartolini I, Risaliti M, Tucci R, Muiesan P, Ringressi MN, Taddei A, Amedei A. Gut microbiota and immune system in liver cancer: Promising therapeutic implication from development to treatment. World J Gastrointest Oncol 2021; 13(11): 1616-1631 |
| URL |
https://www.wjgnet.com/1948-5204/full/v13/i11/1616.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v13.i11.1616 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
